drugs used in asthma Flashcards

1
Q

is a heterogenous disease, usually characterized by chronic airway inflammation. it is defined by the history of respiratory symptoms such as wheeze, SOB, chest tightness, and cough that vary over time and in intensity, together with variable expiratory airflow limitation.

A

asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

study this

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

in asthma patients there is a predominance of what cells that produces humoral response thereby stimulating plasma cells to produce IgE which attaches to Mast cells to produce a complex

A

TH2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

____ secreted by plasma cells binds
the FcεRI receptor on submucosal mast cells and basophils and, when crosslinked by an antigen, induces the release of preformed mediators
such as histamine and leukotrienes, as well as the release of inflammatory cytokines.

A

Unbound IgE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

These cells also migrate into the airway subepithelial mucosa, where they release inflammatory cytokines such as IL-5 and IL-13, which induce goblet cell metaplasia
and mucus production, and act as a chemokine for eosinophils, mast cells, and basophils

A

Th2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The histamine, tryptase, leukotrienes C4
and D4, and prostaglandin D2 released cause the smooth muscle contraction and vascular leakage responsible for the acute bronchoconstriction of the?

A

“early asthmatic response.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

“early asthmatic response” is
often followed in 3–6 hours by a second, more sustained phase of bronchoconstriction, the?

This late response is thought
to be due to cytokines characteristically produced by T2 lymphocytes, especially interleukins (IL) 5, 9, and 13.

A

“late asthmatic response,”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SYMPATHOMIMETIC AGENTS

A

Epinephrine, Ephedrine, Isoproterenol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Beta 2- selective drugs:

A

SABA:Albuterol, Terbutaline, Metaproterenol, Pirbuterol

LABA: Salmeterol, Formeterol

Ultra LABA: Indacaterol, Olodaterol, Vilanterol, Bambuterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Methylxanthine drugs

A

Theophylline, Theobromine, Caffeine, Roflumilast (PDE4 inhibitor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

anti-muscarininc agents

A

SAMA: Ipatropium bromide

LAMA: Tiotropium, Aclidinium, Umeclidinium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CORTICOSTEROIDS

A

beclomethasone, budesonide, ciclesonide,
flunisolide, fluticasone, mometasone, and triamcinolone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

LEUKOTRIENE PATHWAY INHIBITORS

A

zileuton, zafirlukast and montelukast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

TARGETED (MONOCLONAL ANTIBODY)
THERAPY

A

Anti-IgE Monoclonal Antibodies: omalizumab

Anti-IL-5 Therapy:mepolizumab,reslizumab, benralizumab,Dupllumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

-are mainstays in the treatment of
asthma.

-Their binding to β-adrenergic receptors—abundant on
airway smooth muscle cells—stimulates adenylyl cyclase and increases the formation of intracellular cAMP thereby relaxing airway smooth muscle and inhibiting release
of bronchoconstricting mediators from mast cells

A

Adrenoceptor agonists/SYMPATHOMIMETIC AGENTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

is an effective, rapidly acting bronchodilator
when injected subcutaneously (0.4 mL of 1:1000 solution) or inhaled as a microaerosol from a pressurized canister (320 mcg per puff). Maximal bronchodilation is achieved within 15 minutes after inhalation and lasts 60–90 minutes.

A

Epinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

adverse effects of epinephrine

A

Because epinephrine
stimulates α and β1 as well as β2 receptors, tachycardia, arrhythmias, and worsening of angina pectoris are the serious adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

used in China for more than 2000 years
before its introduction into Western medicine in 1924. Comparedwith epinephrine, ephedrine has a longer duration, oral activity, more pronounced central effects, and much lower potency.

A

Ephedrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

is a potent nonselective β1 and β2 bronchodilator.
When inhaled as a microaerosol from a pressurized canister,80–120 mcg isoproterenol causes maximal bronchodilationwithin 5 minutes and has a 60- to 90-minute duration of action.

A

Isoproterenol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

They are effective after inhaled or oral administration
and have a longer duration of action than epinephrine
or isoproterenol.

A

Beta2-Selective Drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

-Given by inhalation, these agents cause bronchodilation equivalent to that produced by isoproterenol. Bronchodilation is maximal within 15 minutes and persists for 3–4 hours.

-Nebulized therapy should
thus be reserved for patients unable to coordinate inhalation from a metered-dose inhaler

A

SABA: Albuterol, terbutaline, metaproterenol, and pirbuterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

are also available in oral form. One
tablet two or three times daily is the usual regimen; the principal adverse effects are skeletal muscle tremor, nervousness, and occasional weakness. This route of administration presents no advantage over inhaled treatment and produces more pronounced
adverse effects and is thus rarely prescribed

A

Albuterol and terbutaline

23
Q

is available for subcutaneous
injection (0.25 mg).

The indications for this route are similar to those for subcutaneous epinephrine—severe asthma requiring emergency treatment when aerosolized therapy is not available or has been ineffective.

  • it should be remembered that its longer duration of action means that cumulative effects
    may be seen after repeated injections.
A

Terbutaline

24
Q

with 12-hour durations
of action

  • These drugs generally
    achieve their long duration of bronchodilating action as a result of high lipid solubility. This permits them to dissolve in the smooth muscle cell membrane in high concentrations or, possibly, attach to “mooring” molecules in the vicinity of the adrenoceptor.
  • These drugs appear to interact with inhaled corticosteroids
  • should not be used as monotherapy for asthma
A

Long-acting β2-selective agonists (LABA), salmeterol and formoterol

25
Q

need to be taken only once a day, but because their prolonged bronchodilation masks symptoms of
bronchial inflammation, they should be used only in combination with an ICS for asthma.

-may be used as monotherapy for treatment of COPD

A

Ultra-long-acting β agonists: indacaterol, olodaterol,
vilanterol, and bambuterol

26
Q

Their major source is beverages (tea,
cocoa, and coffee, respectively). The use of theophylline, once a mainstay of asthma treatment, has almost ceased with demonstration of the greater efficacy of inhaled adrenoceptor agonists for acute asthma and of inhaled anti-inflammatory agents for chronic asthma.

A

METHYLXANTHINES: theophylline, theobromine,
and caffeine.

27
Q

ADVERSE EFFECTS: nausea, vomiting, tremulousness, arrhythmias) and
the requirement for monitoring serum levels because of its narrow therapeutic index

A

theophylline, theobromine,
and caffeine.

28
Q

3 Mechanism of Action of Methylxanthines

A

1.At high concentrations, they can be shown to inhibit several members of the phosphodiesterase (PDE) enzyme family in vitro, thereby increasing concentrations of intracellular cAMP and, in some tissues, cGMP.

2.inhibition of cell surface receptors for
adenosine.

3.enhancement of histone deacetylation

29
Q

inhibition of ___appears to be the most involved in relaxing airway smooth muscle and inhibition of ___ in inhibiting release of cytokines and chemokines,
thus decreasing immune cell migration and activation

A

PDE3,PDE4

30
Q

PDE4 INHIBITOR?

A

roflumilast

31
Q

-produces slight tachycardia, an increase in cardiac output, and an increase in peripheral resistance, potentially raising blood pressure slightly. In sensitive individuals, consumption of a few cups of coffee may result in arrhythmias. High doses of these agents relax vascular
smooth muscle except in cerebral blood vessels

-decrease blood viscosity and may improve
blood flow under certain conditions

A

methylxanthines :Cardiovascular Effects

32
Q

these agents—in sufficient concentration—inhibit antigen-induced release of histamine from lung tissue.

  • improve contractility of skeletal muscle
  • reverse fatigue of the diaphragm in patients with COPD
A

methylxanthines

33
Q

potent atropine analog that is poorly absorbed after aerosol administration and is therefore relatively free of systemic atropinelike effects.

A

SAMA:ipratropium

34
Q

are approved for maintenance
therapy of COPD.

A

LAMA: A single dose of 18
mcg of tiotropium or 62.5 mcg of umeclidinium has a 24-hourduration of action,

  • 400 mcg of aclidinium has a 12-hour duration
35
Q

Greater bronchodilation, with less toxicity from systemic absorption,is achieved with a selective quaternary ammonium derivative of atropine,_____, which can be inhaled in high doses because of its poor absorption into the circulation and poor entry into the central nervous system

A

Ipatropium bromide

36
Q

Afferent pathways in the vagus nerves travel to the central nervous system; efferent pathways from the central nervous system travel to efferent ganglia. Postganglionic fibers release acetylcholine (ACh), which binds to muscarinic receptors on airway smooth muscle. Inhaled materials may provoke bronchoconstriction by several possible mechanisms. First, they may trigger the release of chemical mediators from mast cells. Second, they may stimulate afferent receptors to initiate reflex bronchoconstriction or to release tachykinins (eg, substance P) that directly stimulate smooth muscle contraction.

A

Mechanisms of response to inhaled irritants

37
Q

have long been used in the treatment of asthma and are presumed to act by their broad anti-inflammatory efficacy, mediated in part by inhibition of production of inflammatory cytokines

A

Corticosteroids (specifically, glucocorticoids)

38
Q

They do not relax airway smooth muscle directly but reduce bronchial hyperreactivity and reduce the frequency of asthma exacerbations if taken regularly

A

Corticosteroids (specifically, glucocorticoids)

39
Q
  • effective in improving all indices of asthma control: severity of symptoms, tests of airway caliber and bronchial reactivity, frequency of exacerbations, and quality of life
  • Inhalational treatment is the most effective way to avoid the systemic adverse effects
A

CORTICOSTEROIDS

40
Q

adverse effects: oropharyngeal candidiasis, hoarseness

A

CORTICOSTEROIDS

41
Q
  • were once widely used for asthma management, especially in children,
  • These drugs are thought to act by inhibiting mast cell degranulation and have no direct bronchodilator action.
  • The main indication for current use for reducing symptoms of allergic rhinoconjunctivitis.
A

CROMOLYN & NEDOCROMIL

42
Q

result from the action of 5-lipoxygenase on arachidonic
acid and are synthesized by a variety of inflammatory cells inthe airways, including eosinophils, mast cells, macrophages, and basophils.

A

Leukotrienes

43
Q

is a potent neutrophil chemoattractant,
and LTC4 and LTD4 exert many effects known to occur
in asthma, including bronchoconstriction, increased bronchial reactivity, mucosal edema, and mucus hypersecretion

A

Leukotriene B4 (LTB4)

44
Q

Two approaches to interrupting the leukotriene pathway have been pursued:

A
  1. inhibition of 5-lipoxygenase, thereby preventing leukotriene synthesis
  2. inhibition of the binding of LTD4
    to its receptor on target tissues, thereby preventing its action.
45
Q

preferred by many patients, especially by the parents of asthmatic children, because of often exaggerated concerns over the toxicities of corticosteroids

A

LEUKOTRIENE PATHWAY INHIBITORS: zileuton, zafirlukast and montelukast,

46
Q

inhibits the binding of IgE but does not activate IgE already bound to its receptor and thus does not provoke mast cell degranulation.

A

omalizumab

47
Q

is restricted to patients with severe asthma
and evidence of allergic sensitization, and the dose administered is adjusted for total IgE level and body weight.

Administered by subcutaneous
injection every 2–4 weeks to asthmatic patients,

lowersfree plasma IgE to undetectable levels and significantly reduces the magnitude of both early and late bronchospastic responses to antigen challenge.

A

Omalizumab

48
Q

Omalizumab’s most important clinical effect is?

A

reduction in the frequency and severity of asthma exacerbations, while enabling a reduction in corticosteroid requirements

49
Q

check this

A
50
Q

Two humanized monoclonal antibodies targeting IL-5, ___
and ___ , and another targeting the IL-5 receptor,____ , have recently been developed for the treatment of eosinophilic asthma

A

mepolizumab, reslizumab ,benralizumab

51
Q
  • T2 cells secrete ___ as a pro-eosinophilic cytokine that results in eosinophilic airway inflammation.
  • Although not central to the mechanisms of asthma in all patients, a substantial proportion of patients with severe asthma have airway and peripheral eosinophilia driven by up-regulation of ___-secreting T2 lymphocytes.
A

IL-5

52
Q

brand name:Nucala

generic name?

A

mepolizumab

53
Q

a humanized monoclonal antibody targets IL5 and binds to it

A

Nucala/mepolizumab

54
Q

Nucala blocks the IL5 binding to the ___ IL5 recpetor complex, inhibiting signal

A

Alpha chain